Edmond De Rothschild Holding S.A. Crispr Therapeutics Ag Transaction History
Edmond De Rothschild Holding S.A.
- $5.72 Billion
- Q2 2024
A detailed history of Edmond De Rothschild Holding S.A. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 1,000 shares of CRSP stock, worth $51,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$51,620% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding CRSP
# of Institutions
503Shares Held
57MCall Options Held
1.7MPut Options Held
1.8M-
Capital International Investors Los Angeles, CA7.87MShares$406 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$387 Million3.35% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$153 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$153 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$143 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.03B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....